ark cancer charity Company Information
Company Number
08240913
Registered Address
the ark conference centre, dinwoodie drive, basingstoke, hampshire, RG24 9NN
Industry
Specialist medical practice activities
Telephone
01256360419
Next Accounts Due
September 2025
Group Structure
View All
Shareholders
-0%
ark cancer charity Estimated Valuation
Pomanda estimates the enterprise value of ARK CANCER CHARITY at £77.2k based on a Turnover of £137k and 0.56x industry multiple (adjusted for size and gross margin).
ark cancer charity Estimated Valuation
Pomanda estimates the enterprise value of ARK CANCER CHARITY at £0 based on an EBITDA of £-41.3k and a 4.23x industry multiple (adjusted for size and gross margin).
ark cancer charity Estimated Valuation
Pomanda estimates the enterprise value of ARK CANCER CHARITY at £6.7m based on Net Assets of £2.7m and 2.54x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Ark Cancer Charity Overview
Ark Cancer Charity is a live company located in basingstoke, RG24 9NN with a Companies House number of 08240913. It operates in the specialists medical practice activities sector, SIC Code 86220. Founded in October 2012, it's largest shareholder is unknown. Ark Cancer Charity is a established, micro sized company, Pomanda has estimated its turnover at £137k with declining growth in recent years.
Upgrade for unlimited company reports & a free credit check
Ark Cancer Charity Health Check
Pomanda's financial health check has awarded Ark Cancer Charity a 3.5 rating. We use a traffic light system to show it exceeds the industry average on 2 measures and has 4 areas for improvement. Company Health Check FAQs
2 Strong
3 Regular
4 Weak
Size
annual sales of £137k, make it smaller than the average company (£783.5k)
£137k - Ark Cancer Charity
£783.5k - Industry AVG
Growth
3 year (CAGR) sales growth of -53%, show it is growing at a slower rate (6.8%)
-53% - Ark Cancer Charity
6.8% - Industry AVG
Production
with a gross margin of 52.6%, this company has a comparable cost of product (52.6%)
52.6% - Ark Cancer Charity
52.6% - Industry AVG
Profitability
an operating margin of -30.9% make it less profitable than the average company (11.8%)
-30.9% - Ark Cancer Charity
11.8% - Industry AVG
Employees
with 2 employees, this is below the industry average (13)
- Ark Cancer Charity
13 - Industry AVG
Pay Structure
on an average salary of £33.1k, the company has an equivalent pay structure (£33.1k)
- Ark Cancer Charity
£33.1k - Industry AVG
Efficiency
resulting in sales per employee of £68.5k, this is equally as efficient (£76.6k)
- Ark Cancer Charity
£76.6k - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- - Ark Cancer Charity
- - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- - Ark Cancer Charity
- - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Ark Cancer Charity
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 361 weeks, this is more cash available to meet short term requirements (59 weeks)
361 weeks - Ark Cancer Charity
59 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 3.5%, this is a lower level of debt than the average (37.4%)
3.5% - Ark Cancer Charity
37.4% - Industry AVG
ARK CANCER CHARITY financials
Ark Cancer Charity's latest turnover from December 2023 is £137 thousand and the company has net assets of £2.7 million. According to their latest financial statements, we estimate that Ark Cancer Charity has 2 employees and maintains cash reserves of £677.9 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | |
---|---|---|---|---|---|---|---|---|---|---|---|
Turnover | 137,031 | 154,730 | 174,399 | 1,316,756 | 355,859 | 270,101 | 369,205 | 250,471 | 307,967 | 175,066 | 222,844 |
Other Income Or Grants | |||||||||||
Cost Of Sales | |||||||||||
Gross Profit | |||||||||||
Admin Expenses | |||||||||||
Operating Profit | |||||||||||
Interest Payable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Interest Receivable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3,556 | 0 | 0 |
Pre-Tax Profit | -4,670 | -50,055 | 67,231 | 1,093,294 | 298,978 | 211,839 | 275,065 | 157,454 | 263,186 | 145,928 | 197,668 |
Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit After Tax | -4,670 | -50,055 | 67,231 | 1,093,294 | 298,978 | 211,839 | 275,065 | 157,454 | 263,186 | 145,928 | 197,668 |
Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Retained Profit | -4,670 | -50,055 | 67,231 | 1,093,294 | 298,978 | 211,839 | 275,065 | 157,454 | 263,186 | 145,928 | 197,668 |
Employee Costs | |||||||||||
Number Of Employees | |||||||||||
EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | |
---|---|---|---|---|---|---|---|---|---|---|---|
Tangible Assets | 7,010 | 1,800 | 2,591 | 545 | 1,113 | 1,088 | 1,875 | 2,669 | 1,369 | 1,958 | 2,320 |
Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Fixed Assets | 7,010 | 1,800 | 2,591 | 545 | 1,113 | 1,088 | 1,875 | 2,669 | 1,369 | 1,958 | 2,320 |
Stock & work in progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Trade Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Group Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Misc Debtors | 9,838 | 9,053 | 2,435 | 1,131,436 | 13,285 | 10,808 | 9,761 | 10,434 | 20,073 | 18,578 | 14,107 |
Cash | 677,932 | 831,506 | 2,317,626 | 1,518,662 | 1,543,087 | 1,245,893 | 1,030,082 | 766,409 | 592,020 | 325,588 | 183,133 |
misc current assets | 2,058,596 | 2,002,016 | 405,840 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total current assets | 2,746,366 | 2,842,575 | 2,725,901 | 2,650,098 | 1,556,372 | 1,256,701 | 1,039,843 | 776,843 | 612,093 | 344,166 | 197,240 |
total assets | 2,753,376 | 2,844,375 | 2,728,492 | 2,650,643 | 1,557,485 | 1,257,789 | 1,041,718 | 779,512 | 613,462 | 346,124 | 199,560 |
Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Trade Creditors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other current liabilities | 97,458 | 183,788 | 17,850 | 7,231 | 7,367 | 6,649 | 2,417 | 15,276 | 6,680 | 2,528 | 1,892 |
total current liabilities | 97,458 | 183,788 | 17,850 | 7,231 | 7,367 | 6,649 | 2,417 | 15,276 | 6,680 | 2,528 | 1,892 |
loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total liabilities | 97,458 | 183,788 | 17,850 | 7,231 | 7,367 | 6,649 | 2,417 | 15,276 | 6,680 | 2,528 | 1,892 |
net assets | 2,655,918 | 2,660,587 | 2,710,642 | 2,643,412 | 1,550,118 | 1,251,140 | 1,039,301 | 764,236 | 606,782 | 343,596 | 197,668 |
total shareholders funds | 2,655,918 | 2,660,587 | 2,710,642 | 2,643,412 | 1,550,118 | 1,251,140 | 1,039,301 | 764,236 | 606,782 | 343,596 | 197,668 |
Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | |
---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities | |||||||||||
Operating Profit | |||||||||||
Depreciation | 1,125 | 791 | 791 | 567 | 161 | 1,099 | 1,034 | 800 | 590 | 572 | 418 |
Amortisation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Debtors | 785 | 6,618 | -1,129,001 | 1,118,151 | 2,477 | 1,047 | -673 | -9,639 | 1,495 | 4,471 | 14,107 |
Creditors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accruals and Deferred Income | -86,330 | 165,938 | 10,619 | -136 | 718 | 4,232 | -12,859 | 8,596 | 4,152 | 636 | 1,892 |
Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash flow from operations | |||||||||||
Investing Activities | |||||||||||
capital expenditure | 0 | ||||||||||
Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
cash flow from investments | 0 | ||||||||||
Financing Activities | |||||||||||
Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long term loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
share issue | |||||||||||
interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3,556 | 0 | 0 |
cash flow from financing | 1 | 0 | -1 | 0 | 0 | 0 | 0 | 0 | 3,556 | 0 | 0 |
cash and cash equivalents | |||||||||||
cash | -153,574 | -1,486,120 | 798,964 | -24,425 | 297,194 | 215,811 | 263,673 | 174,389 | 266,432 | 142,455 | 183,133 |
overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
change in cash | -153,574 | -1,486,120 | 798,964 | -24,425 | 297,194 | 215,811 | 263,673 | 174,389 | 266,432 | 142,455 | 183,133 |
ark cancer charity Credit Report and Business Information
Ark Cancer Charity Competitor Analysis
Perform a competitor analysis for ark cancer charity by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other micro companies, companies in RG24 area or any other competitors across 12 key performance metrics.
ark cancer charity Ownership
ARK CANCER CHARITY group structure
Ark Cancer Charity has no subsidiary companies.
Ultimate parent company
ARK CANCER CHARITY
08240913
ark cancer charity directors
Ark Cancer Charity currently has 4 directors. The longest serving directors include Ms Sandra Fell (Oct 2012) and Mr Myrddin Rees (Oct 2012).
officer | country | age | start | end | role |
---|---|---|---|---|---|
Ms Sandra Fell | United Kingdom | 79 years | Oct 2012 | - | Director |
Mr Myrddin Rees | 74 years | Oct 2012 | - | Director | |
Mr Robert Finlayson | 67 years | Jun 2014 | - | Director | |
Mr Ian Harrison | 60 years | Jun 2023 | - | Director |
P&L
December 2023turnover
137k
-11%
operating profit
-42.4k
0%
gross margin
52.7%
-5.08%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2023net assets
2.7m
0%
total assets
2.8m
-0.03%
cash
677.9k
-0.18%
net assets
Total assets minus all liabilities
ark cancer charity company details
company number
08240913
Type
Private Limited by guarantee without Share Capital Exempt from using Limited
industry
86220 - Specialist medical practice activities
incorporation date
October 2012
age
12
incorporated
UK
ultimate parent company
accounts
Total Exemption Full
last accounts submitted
December 2023
previous names
ark cancer centre charity (May 2023)
ark centre cancer charity (November 2013)
accountant
MARK DICKINSON
auditor
-
address
the ark conference centre, dinwoodie drive, basingstoke, hampshire, RG24 9NN
Bank
-
Legal Advisor
-
ark cancer charity Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to ark cancer charity.
ark cancer charity Companies House Filings - See Documents
date | description | view/download |
---|